Blizzy Code Nature Vaccines
- An effective live-attenuated Zika vaccine candidate with a modified 5′ untranslated region
- Immunization of broiler chickens with five newly identified surface-exposed proteins unique to Clostridium perfringens causing necrotic enteritis
- Assessing the generation of tissue resident memory T cells by vaccines
- Commercial influenza vaccines vary in HA-complex structure and in induction of cross-reactive HA antibodies
- Process development for an effective COVID-19 vaccine candidate harboring recombinant SARS-CoV-2 delta plus receptor binding domain produced by Pichia pastoris
- Long-term measles antibody profiles following different vaccine schedules in China, a longitudinal study
- Progress towards a glycoconjugate vaccine against Group A Streptococcus
- mRNA vaccines and hybrid immunity use different B cell germlines against Omicron BA.4 and BA.5
- Protection from SARS-CoV-2 Variants by MVAs expressing matched or mismatched S administered intranasally to mice
- Risk of death following COVID-19 vaccination or positive SARS-CoV-2 test in young people in England
- Novel immune modulatory vaccines targeting TGFβ
- Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis
- A protective measles virus-derived vaccine inducing long-lasting immune responses against influenza A virus H7N9
- Immunization against Zika by entrapping live virus in a subcutaneous self-adjuvanting hydrogel
- DNA origami presenting the receptor binding domain of SARS-CoV-2 elicit robust protective immune response